⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVXL News
Anavex Life Sciences
Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
AVXL
Form 8-K
sec.gov
AVXL
Form 8-K
sec.gov
AVXL
Form 8-K
sec.gov
AVXL
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
globenewswire.com
AVXL
Form 8-K
sec.gov
AVXL
Form 8-K
sec.gov
AVXL
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
globenewswire.com
AVXL
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease
globenewswire.com
AVXL
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Shareholders to Inquire about Securities Investigation
accessnewswire.com
AVXL